Health Enhancement Products Announces Grant to Wayne State University to Analyze...

Health Enhancement Products Announces Grant to Wayne State University to Analyze
Effects of PAZ Organic Compounds On Cholesterol and Inflammation

SCOTTSDALE, Ariz. and DETROIT, March 30, 2009 (GLOBE NEWSWIRE) -- Health
Enhancement Products, Inc. (OTCBB:HEPI) has awarded a grant to the Department of
Nutrition and Food Science to conduct a study to confirm the therapeutic effects
of its ProAlgaZyme (PAZ) bioactive compound in reducing LDL cholesterol and
C-reactive protein, a protein found in the blood in response to inflammation.

Wayne State University ranks among the nation's top 50 public universities
engaged in basic and applied biomedical research. The Department of Nutrition
and Food Science conducts research in obesity and diabetes, body weight
management, lipid and lipoprotein metabolism, nutrition and cancer, oxidative
stress, diet and aging, gene expression, metabolomics, food safety and food
bacteria.

The study will isolate the various bioactive components and later test for
significant changes in LDL cholesterol and C-reactive protein. Upon completion
of the study, Wayne State will publish a scientific paper describing the final
results, as well as the means and methods employed, to be authored by the
principal investigator, Dr. Smiti Gupta, associate professor of nutrition and
food at WSU.

Once the study is accepted by HEPI, the Company will investigate further trials
with an aim toward garnering a share of the nutraceutical and functional food
market. In what economists consider a disastrous year for business in general,
nutraceutical and functional food marketers are experiencing real growth. In the
EU and U.S. combined, functional food sales grew at an adjusted 30% annualized
rate in 2008, and 2009 appears to be on track to repeat the strong sales volume.
According to Euromonitor International Data, the global health and wellness
market has surged past the $570 billion mark in 2008, with functional
representing the fastest growing segment at $152 billion annualized.

"As a food additive or performance enhancer, PAZ will likely boost the
beneficial aspects of functional foods, supplements, sports drinks and composite
nutraceuticals," states John Gorman, the company's sales director. "We see PAZ
as having great potential for improving the health of Americans and those
seeking wellness everywhere."

About Wayne State University

Wayne State University is one of the nation's pre-eminent public research
universities in an urban setting, ranking in the top 50 R&D expenditures of all
public universities by the National Science Foundation. Through its
multidisciplinary approach to research and education, and its ongoing
collaboration with government, industry and other institutions, the university
seeks to enhance economic growth and improve the quality of life in the city of
Detroit, state of Michigan and throughout the world.

About Health Enhancement Products, Inc.

Health Enhancement Products, Inc. is a nutraceutical company engaged in the
development of a dietary supplement product using only pure, all-natural
ingredients. The Company's premier product is ProAlgaZyme (PAZ), a liquid
product drawn from living algae grown in purified water. The water in which the
algae is grown is drawn off, filtered and bottled as ProAlgaZyme.

Safe Harbor Statement

Except for any historical information, the matters discussed in this press
release contain forward-looking statements within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934. These forward-looking statements involve risks and uncertainties. A number
of factors could cause actual results to differ from those indicated in the
forward-looking statements, including the timing of completion of a trial,
actual future clinical trial results being different than the results the
company has obtained to date, and the company's ability to secure funding. Such
statements are subject to a number of assumptions, risks and uncertainties.
Readers are cautioned that such statements are not guarantees of future
performance and those actual results or developments may differ materially from
those set forth in the forward-looking statements. The company undertakes no
obligation to publicly update or revise forward-looking statements, whether as a
result of new information or otherwise.

For more information, please visit www.heponline.com.

-0-
CONTACT: Wayne State University
Julie O'Connor, Director of Research Communications
(313) 577-8845
ag2712@wayne.edu

Health Enhancement Products, Inc.
John Gorman, Director of Sales
(480) 385-3800
john@heponline.com